Europe Negative Pressure Wound Therapy Market Size
| Study Period | 2018 - 2028 |
| Base Year For Estimation | 2021 |
| Forecast Data Period | 2023 - 2028 |
| Market Size (2023) | USD 0.85 Billion |
| Market Size (2028) | USD 1.09 Billion |
| CAGR (2023 - 2028) | 5.06 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Negative Pressure Wound Therapy Market Analysis
The Europe Negative Pressure Wound Therapy Market size is expected to grow from USD 0.85 billion in 2023 to USD 1.09 billion by 2028, at a CAGR of 5.06% during the forecast period (2023-2028).
The COVID-19 pandemic caused collateral damage in health care regarding reduced hospital submissions or postponed treatment of other acute or chronically ill patients. For instance, the article published in the International Wound Journal in February 2021 included sixty-three patients diagnosed with any kind of ulceration or chronic wound in the survey. Out of these, 14% of patients' diagnostic workup or hospitalization was cancelled or delayed. 36% could not visit their primary care physician as usual for advice. The survey indicated that Germany's COVID-19 pandemic impaired access to clinical management of chronic wounds. Thus, COVID-19 adversely impacted the studied market; however, as the pandemic has currently subsided, the market is expected to experience pre-pandemic growth levels during the study's forecast period.
In addition, the increasing number of accidents and traumatic events, rising chronic wounds such as diabetic foot ulcers, and technological advancements in NPWT devices are actively affecting the growth of the studied market.
For instance, an article published in Diabetes Research and Clinical Practice Journal in February 2021 stated that 69% (154) of patients in Germany and 70% (69) in Czech Republic experienced at least one diabetic foot ulcers (DFU) recurrence. The study stated that cumulative DFU recurrence was approximately 70% in 15 years in both groups. The high incidence of diabetic foot ulcers and its recurrence is expected to boost the demand for negative pressure wound therapy market.
Furthermore, according to the European Pressure Ulcer Advisory Panel 2022 report, Pressure Ulcer Day is hosted in November every year in Europe to spread awareness about the disease. The upcoming event was likely to be hosted in November 2022 with an aim to stop pressure ulcer. Such events are likely to spread awareness regarding the negative pressure wound therapy in the management of pressure ulcer which is projected to boost the growth of the studied market.
Therefore, owing to the aforementioned factors such as the rising prevalence of various chronic
wounds and the rising awareness about the treatment of chronic wounds, the studied market is anticipated to witness growth over the analysis period. however, the high cost of devices and treatment and complications associated With NPWT devices are likely to impede the market growth.
Europe Negative Pressure Wound Therapy Market Trends
This section covers the major market trends shaping the Europe Negative Pressure Wound Therapy Market according to our research experts:
Diabetic Foot Ulcers are Expected to Witness Growth Over The Forecast Period.
Diabetic Foot Ulcers (DFU) is one of the most common complications associated with Diabetes and are posing a significant burden on several countries across the European region.
Diabetic foot ulcer occurs in approximately 15% of patients with diabetes and therefore the increasing diabetic population in the region is contributing to the dominant share of the segment. For instance, according to the International Diabetes Federation Diabetes Atlas, February 2022 report, an estimated 61 million adults (20-79 years) were living with diabetes in the Europe Region in 2021. The number of adults with diabetes is predicted to rise to 69 million by 2045, an increase of 13%. The surge in the prevalence of diabetes among all ages in the European Region is likely to increase the cases of diabetic foot ulcers in the region which is ultimately projected to augment the segment's growth.
The launches and acquisitions by the market players are likely to augment the market growth. For instance, in April 2021, Noventure, a Spain-based company acquired the Ulkox and Oleoabrax products, based on an Olea Europaea leaf extract wound-healing technology. Such developments are expected to boost the segment growth in the region.
Germany is is Expected to Dominate the Europe Negative Pressure Wound Therapy Market.
Germany is expected to dominate the market owing to factors such as the rising incidence of diabetic foot ulcer cases, the strong presence of industry players in the region, better healthcare infrastructure, awareness among people and healthcare industry stakeholders about available technologies, and the high concentration of market players in the country.
The approvals, launches, acquisitions, and partnerships by the key market players in the country are projected to boost the market growth. In June 2021, Bactiguard and German company Schülke & Mayr GmbH signed a distribution agreement for Bactiguard’s range of wound care solutions to German hospitals. The collaboration is predicted to augment the demand for wound management in the country and ultimately boost the market growth.
The Federal Statistical Office (Destatis) August 2022 report stated that approximately 22,300 children aged under 15 years were harmed in road traffic accidents in 2021 in Germany. The accidents are associated with developing a wound that requires negative pressure wound therapy for its management which is ultimately boosting the market growth.
Therefore, owing to the aforementioned factors, the studied market's growth is anticipated in Germany.
Europe Negative Pressure Wound Therapy Industry Overview
The Europe Negative Pressure Wound Therapy Market is slightly consolidated in nature due to the presence of a few companies operating regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. Some major players are Molnlycke Health Care AB, ConvaTec Inc., Cardinal Health, Inc., Smith & Nephew plc, 3M, Talley Group Limited, Devon Medical, Inc, Medela AG, and DeRoyal Industries, Inc.
Europe Negative Pressure Wound Therapy Market Leaders
ConvaTec Inc.
Cardinal Health, Inc.
Smith & Nephew plc
Mölnlycke Health Care AB
3 M (Acelity, Inc.)
*Disclaimer: Major Players sorted in no particular order
Europe Negative Pressure Wound Therapy Market News
- In June 2022, Healiva, a Switzerland-based company that provides patients with chronic and acute wounds with life-improving precision medicine, acquired two innovative cell therapy assets from Smith&Nephew. The acquisition allowed Healiva to establish one of the world’s broadest portfolios of affordable, personalized, end-to-end wound care consisting of enzyme technology, autologous & allogenic cell therapies, and medical devices.
- In May 2022, the Technical University of Munich (TUM) in Germany developed a new kind of film dressing using mucin molecules that can not only protect wounds like conventional dressings but also add active drugs to accelerate wound healing, expel bacteria, inhibit inflammation, and finally decompose on the skin by itself, which is a new revelation for sensitive skin.
Europe Negative Pressure Wound Therapy Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Accidents and Traumatic Events
4.2.2 Rising Chronic Wounds Such as Diabetic Foot Ulcers
4.2.3 Technological Advancements in the NPWT Devices
4.3 Market Restraints
4.3.1 High Cost of Device and Treatment
4.3.2 Complications Associated With NPWT Device
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product
5.1.1 Re-Usable Device
5.1.2 Single-Use Device
5.2 By Wound Type
5.2.1 Diabetic Foot Ulcer
5.2.2 Pressure Ulcer
5.2.3 Venous Leg Ulcer
5.2.4 Burn Wounds
5.2.5 Others
5.3 By End-User
5.3.1 Hospital
5.3.2 Homecare
5.3.3 Others
5.4 Geography
5.4.1 Germany
5.4.2 United Kingdom
5.4.3 France
5.4.4 Italy
5.4.5 Spain
5.4.6 Rest of Europe
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Molnlycke Health Care AB
6.1.2 ConvaTec Inc.
6.1.3 Cardinal Health, Inc.
6.1.4 Smith & Nephew plc
6.1.5 3M (Acelity L.P. Inc.)
6.1.6 Talley Group Limited
6.1.7 Devon Medical, Inc
6.1.8 Medela AG
6.1.9 DeRoyal Industries, Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Europe Negative Pressure Wound Therapy Industry Segmentation
As per the scope of the report, negative-pressure wound therapy (NPWT) is a therapeutic technique using a suction dressing to remove excess exudation and promote healing in acute or chronic wounds and second and third-degree burns. This report covers the study of types of NPWT products and their applications across various injuries/ulcers. The Europe Negative Pressure Wound Therapy Market is Segmented by Product (Re-Usable Device and Single-Use Device) Wound Type (Diabetic Foot Ulcer, Pressure Ulcer, Venous Leg Ulcer, Burn Wounds, and Others), End-User (Hospital, Homecare, and Others), and Country (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.
| By Product | |
| Re-Usable Device | |
| Single-Use Device |
| By Wound Type | |
| Diabetic Foot Ulcer | |
| Pressure Ulcer | |
| Venous Leg Ulcer | |
| Burn Wounds | |
| Others |
| By End-User | |
| Hospital | |
| Homecare | |
| Others |
| Geography | |
| Germany | |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
Europe Negative Pressure Wound Therapy Market Research FAQs
How big is the Europe Negative Pressure Wound Therapy Market?
The Europe Negative Pressure Wound Therapy Market size is expected to reach USD 0.85 billion in 2023 and grow at a CAGR of 5.06% to reach USD 1.09 billion by 2028.
What is the current Europe Negative Pressure Wound Therapy Market size?
In 2023, the Europe Negative Pressure Wound Therapy Market size is expected to reach USD 0.85 billion.
Who are the key players in Europe Negative Pressure Wound Therapy Market?
ConvaTec Inc., Cardinal Health, Inc., Smith & Nephew plc, Mölnlycke Health Care AB and 3 M (Acelity, Inc.) are the major companies operating in the Europe Negative Pressure Wound Therapy Market.
Europe Negative Pressure Wound Therapy Industry Report
Statistics for the 2023 Europe Negative Pressure Wound Therapy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Negative Pressure Wound Therapy analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.
